Experiments on Black Babies

"What you may call a serious side effect in the U.S. is not a serious side effect in Kampala." This is a statement from a lead doctor in Uganda. The article, U.S. Officials Knew of AIDS Drug Risks provides the worst case scenario of testing new drugs on black babies, yet again.

"The government's research on using an AIDS drug to protect African babies was so flawed that health officials had to use blood tests after the fact to confirm patients got the medicine. Ultimately, they had to acknowledge the study broke federal patient protection rules. "

Nevirapine is an antiretroviral drug marketed in the United States as Viramune. It has been used since the 1990s to treat adult AIDS patients and is known to have potentially lethal side effects like liver damage and severe rashes when taken over time.

In 1997, NIH began studying in Uganda whether it could be given safely in single doses to stop mother-to-baby HIV transmission. That research showed it could reduce transmission in as many as half the births.

But by early 2002, an NIH auditor, the agency's medical safety experts and the drug's maker all disclosed widespread problems about the U.S.-funded research in Uganda.

Statistics and lies!